Literature DB >> 19214600

Is extensive cervical laminoplasty an effective treatment for spinal cord sarcoidosis combined with cervical spondylosis?

Keisuke Oe1, Minoru Doita, Hiroshi Miyamoto, Fumio Kanda, Masahiro Kurosaka, Masatoshi Sumi.   

Abstract

Patients with neurosarcoidosis are usually initially treated with steroid administration even when they have concomitant cord compression on magnetic resonance imaging (MRI). Operative intervention may be indicated in patients with spinal cord sarcoidosis requiring either tissue biopsy for diagnosis or associated with progressive neurologic symptoms. However, there have been no previous reports describing clinical outcomes of laminoplasty for spinal cord sarcoidosis. The objectives of this study are to investigate whether extensive cervical laminoplasty is an effective treatment for spinal cord sarcoidosis combined with spondylotic changes and/or cervical spinal canal stenosis. Open-door laminoplasty was performed in three patients with spinal cord sarcoidosis. All patients received intensive corticosteroid therapy after the operation MRI imaging was performed in all patients before and after the operation. Operative outcomes were not satisfactory and the clinical courses of the patients fluctuated after corticosteroid therapy. Daily life activities were not significantly improved after treatments in any of the three patients, and in the long-term follow-up period the clinical course of one patient was one of inexorable deterioration to a state of quadriplegia. The possibility of spinal cord sarcoidosis should be included in the differential diagnosis, when a distinct high signal intensity area is observed within the spinal cord on T2-weighted MR images in patients with spondylotic changes. Laminoplasty is not an effective intervention for the treatment of spinal cord sarcoidosis even when patients have spondylotic changes and/or a constitutionally narrowing cervical spinal canal. Patients with neurosarcoidosis should be treated first with steroid administration even when they have concomitant cord compression on MRI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214600      PMCID: PMC2899469          DOI: 10.1007/s00586-009-0891-2

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  29 in total

1.  Solitary intramedullary neurosarcoidosis: role of MRI in early detection.

Authors:  G R Hayat; T P Walton; K R Smith; D S Martin; A N Manepalli
Journal:  J Neuroimaging       Date:  2001-01       Impact factor: 2.486

2.  Pathomechanism, pathogenesis, and results of treatment in cervical spondylotic myelopathy caused by dynamic canal stenosis.

Authors:  K Fukui; O Kataoka; T Sho; M Sumi
Journal:  Spine (Phila Pa 1976)       Date:  1990-11       Impact factor: 3.468

3.  Differential response to corticosteroid therapy of MRI findings and clinical manifestations in spinal cord sarcoidosis.

Authors:  H Koike; K Misu; K Yasui; T Kameyama; T Ando; T Yanagi; G Sobue
Journal:  J Neurol       Date:  2000-07       Impact factor: 4.849

4.  Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy.

Authors:  J L Dumas; D Valeyre; C Chapelon-Abric; C Belin; J C Piette; H Tandjaoui-Lambiotte; M Brauner; D Goldlust
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

5.  Correlation between operative outcomes of cervical compression myelopathy and mri of the spinal cord.

Authors:  Y Morio; R Teshima; H Nagashima; K Nawata; D Yamasaki; Y Nanjo
Journal:  Spine (Phila Pa 1976)       Date:  2001-06-01       Impact factor: 3.468

Review 6.  Sarcoidosis presenting as an isolated intramedullary tumor.

Authors:  M Levivier; J Brotchi; D Balériaux; B Pirotte; J Flament-Durand
Journal:  Neurosurgery       Date:  1991-08       Impact factor: 4.654

7.  Postoperative expansion of intramedullary high-intensity areas on T2-weighted magnetic resonance imaging after cervical laminoplasty.

Authors:  Atsushi Seichi; Katsushi Takeshita; Hiroshi Kawaguchi; Susumu Nakajima; Toru Akune; Kozo Nakamura
Journal:  Spine (Phila Pa 1976)       Date:  2004-07-01       Impact factor: 3.468

8.  Myelopathic neurosarcoidosis: diagnostic value of enhanced MRI.

Authors:  M K Sauter; H S Panitch; D A Kristt
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

9.  Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis.

Authors:  Manica Sodhi; Karla Pearson; Eric S White; Daniel A Culver
Journal:  Respir Med       Date:  2008-10-02       Impact factor: 3.415

10.  Segmental motor paralysis after expansive open-door laminoplasty.

Authors:  Kazuhiro Chiba; Yoshiaki Toyama; Morio Matsumoto; Hirofumi Maruiwa; Masahiko Watanabe; Kiyoshi Hirabayashi
Journal:  Spine (Phila Pa 1976)       Date:  2002-10-01       Impact factor: 3.468

View more
  3 in total

1.  Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients.

Authors:  Ken Sakushima; Ichiro Yabe; Fumihito Nakano; Kazuto Yoshida; Yasutaka Tajima; Hideki Houzen; Yasunori Maruo; Hidenao Sasaki
Journal:  J Neurol       Date:  2011-05-07       Impact factor: 4.849

2.  FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis.

Authors:  Ken Sakushima; Ichiro Yabe; Tohru Shiga; Moemi Yashima-Yamada; Sachiko Tsuji-Akimoto; Satoshi Terae; Hidenao Sasaki
Journal:  J Neurol       Date:  2010-09-05       Impact factor: 4.849

3.  Spinal cord sarcoidosis in Japan: utility of cerebrospinal fluid examination and nerve conduction study for diagnosis and prognosis prediction.

Authors:  Miwako Fujisawa; Michiaki Koga; Ryota Sato; Mariko Oishi; Yukio Takeshita; Takashi Kanda
Journal:  J Neurol       Date:  2022-04-17       Impact factor: 6.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.